Avanza Fonder’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Avanza Fonder's EW Position: Q3 2026 in Review
Avanza Fonder increased its Edwards Lifesciences (EW) stake by 15% in Q3 2026, buying an estimated $872K and bringing the position to 76,105 shares worth $6.57M. The position accounts for 0.13% of the portfolio, ranked #145.
Avanza Fonder first reported a position in EW in Q4 2024 and has held it in 8 quarters since. 1,342 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Avanza Fonder held 76,105 shares of Edwards Lifesciences worth $6.57M as of Q3 2026.
- Avanza Fonder bought 9,811 Edwards Lifesciences shares in Q3 2026, an estimated $872K.
- Edwards Lifesciences made up 0.13% of Avanza Fonder's portfolio in Q3 2026, its #145 holding.
- Avanza Fonder first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 8 quarters since.
- 1,342 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Avanza Fonder's 13F filing for Q3 2026, filed 13 Oct 2026.